1. Home
  2. NPWR vs TNXP Comparison

NPWR vs TNXP Comparison

Compare NPWR & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NET Power Inc.

NPWR

NET Power Inc.

HOLD

Current Price

$1.58

Market Cap

193.9M

Sector

Energy

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.77

Market Cap

192.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPWR
TNXP
Founded
2010
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.9M
192.9M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
NPWR
TNXP
Price
$1.58
$12.77
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
722.2K
531.0K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
N/A
$558.11
Revenue Next Year
N/A
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$1.46
$10.03
52 Week High
$5.20
$69.65

Technical Indicators

Market Signals
Indicator
NPWR
TNXP
Relative Strength Index (RSI) 39.22 52.47
Support Level $1.46 $11.98
Resistance Level $1.84 $13.17
Average True Range (ATR) 0.11 0.85
MACD -0.00 0.11
Stochastic Oscillator 16.42 56.17

Price Performance

Historical Comparison
NPWR
TNXP

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: